BLCO

Bausch + Lomb Corporation (BLCO)

NYSE
$16.74
$-0.30
(-1.76%)
Bausch + Lomb Corporation (BLCO) Live Price Chart
Page last updated: 2026-02-12 18:37:39

Key Market Data

$5.93B

$17.07

$21.95

$10.45

$17.03

$-0.30

-1.76%

120K

Bausch + Lomb Corporation (BLCO) Stock Price Today

Bausch + Lomb Corporation (BLCO) is currently trading at $16.74 as of 2026-02-12 18:37:39, reflecting a -1.76% move ($-0.30) from the previous close.

In the short term, the stock has returned -337.76% over the past four weeks. Over the last 12 months, Bausch + Lomb Corporation has recorded a +1.79% price change, indicating a stable performance relative to the broader market.

Bausch + Lomb Corporation (BLCO) 7-Day Stock Price Changes

Over the past seven days, Bausch + Lomb Corporation has traded within a short-term range shaped by market sentiment in the OPHTHALMIC GOODS sector. During this period, the stock moved from its previous closing price of $16.48 to the latest recorded price of $16.74, reflecting an intraday change of -1.76%. Daily movements highlight shifts in trading volume (119,776), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, BLCO has delivered a -337.76% return over the past month and a +1.79% change in the last 12 months, indicating a stable trend relative to its broader sector peers.

How to Buy Bausch + Lomb Corporation (BLCO)

You can buy and trade BLCO on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account
Step 1: Create and Verify Your MEXC Account
Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.
Step 2: Deposit Funds Into Your Account
Step 2: Deposit Funds Into Your Account
Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.
Step 3: Search for BLCO and Execute Your Trade
Step 3: Search for BLCO and Execute Your Trade
Open the trading page, enter BLCO in the search bar, select the amount of BLCO you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is Bausch + Lomb Corporation (BLCO)?

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Bausch + Lomb Corporation Information

Industry
OPHTHALMIC GOODS
Employees
13,500
Sector
OPHTHALMIC GOODS
Company Website

Frequently Asked Questions (FAQ)

1.What is the current share price of Bausch + Lomb Corporation?
The latest trading price for Bausch + Lomb Corporation (Common Stock) is $ 16.74, compared with a previous closing price of $ 17.03. That means the stock has moved -1.76% so far today. Intraday price updates and recent trading activity for BLCO can be tracked on the live chart and quote section on this page.
2.Is Bausch + Lomb Corporation stock going up or down?
Looking at recent performances, BLCO has returned -337.76% over the past month, +15.73% over the last six months and +1.79% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe stable price momentum for Bausch + Lomb Corporation stock, but keep in mind that past returns do not guarantee future results.
3.Where does BLCO currently sit relative to its 52-week high and low?
In the most recent 52-week period, Bausch + Lomb Corporation has traded between a low of $ 10.45 and a high of $ 17.86. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether BLCO is currently nearer the top or the bottom of its one-year trading band.
4.How is Bausch + Lomb Corporation classified by sector and industry?
Bausch + Lomb Corporation is classified in the OPHTHALMIC GOODS sector. In practice, this means Bausch + Lomb Corporation is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing BLCO’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the OPHTHALMIC GOODS sector could influence Bausch + Lomb Corporation’s performance.
5.Where is Bausch + Lomb Corporation listed and how large is it by market value?
Bausch + Lomb Corporation is listed on the NYSE stock exchange in United States. Based on a market capitalization of $ 5.93B, the company is classified as a Mid-cap stock. Market cap gives a quick sense of Bausch + Lomb Corporation's size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.
6.What does BLCO's EPS tell investors about its profitability?
Trailing-twelve-month EPS of $ -0.86 summarises how much profit Bausch + Lomb Corporation has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.
7.How can I track Bausch + Lomb Corporation's financial performance over time?
To follow Bausch + Lomb Corporation's financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how BLCO is performing and how the market is responding.
8.When is Bausch + Lomb Corporation expected to report earnings?
Bausch + Lomb Corporation's next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for BLCO, as they provide updated information on revenue, profitability and management's outlook.
9.What usually comes out in Bausch + Lomb Corporation's earnings reports?
Bausch + Lomb Corporation's earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether BLCO is meeting, beating or missing expectations.
10.How can I stay informed about Bausch + Lomb Corporation's results and guidance?
You can stay up to date on Bausch + Lomb Corporation by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for BLCO on this page helps you see how new information is being reflected in the stock.
11.Does Bausch + Lomb Corporation pay a regular cash dividend to its shareholders?
Bausch + Lomb Corporation Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of 0 at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor BLCO's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.
12.What are the current dividend yield and dividend payout ratio for BLCO?
Based on the latest earnings data, BLCO has a dividend yield of 0 and a dividend payout ratio of 0. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether Bausch + Lomb Corporation is an attractive income stock. The dividend payout ratio measures what percentage of earnings Bausch + Lomb Corporation distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.
13.What kind of business is Bausch + Lomb Corporation?
Bausch + Lomb Corporation is a publicly traded company in the OPHTHALMIC GOODS industry within the OPHTHALMIC GOODS sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.
14.How is BLCO valued in terms of P/E ratio and EPS?
Bausch + Lomb Corporation currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of $ -0.86. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of Bausch + Lomb Corporation's earnings. Comparing BLCO's P/E and EPS to those of other OPHTHALMIC GOODS companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as Bausch + Lomb Corporation

Largest Market Cap

See US stocks with the highest market capitalization

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

BLCO-to-USD Calculator

Amount

BLCO
BLCO
USD
USD

1 BLCO = 16.735 USD